Guanidine‐Derived Polymeric Nanoinhibitors Target the Lysosomal V‐ATPase and Activate AMPK Pathway to Ameliorate Liver Lipid Accumulation
Advanced Science · 2025
DOI: 10.1002/advs.202408906 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Yunfei Zhao und 14 weiteren Autor:innen. Beteiligte Einrichtung: Chongqing Medical University, College of Pharmacy, Chongqing Key Laboratory for Pharmaceutical Metabolism Research, Chongqing Pharmacodynamic Evaluat…. Hauptthemen laut MEDLINE: Guanidine, Liver, Lipid Metabolism, Polymers. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key R&D Program of China, Natural Science Foundation of Chongqing,.
Abstract (Originalsprache)
Current research efforts in polymer and nanotechnology applications are primarily focused on cargo delivery to enhance the therapeutic index, with limited attention being paid to self‐molecularly targeted nanoparticles, which may also exhibit significant therapeutic potential. Long‐term and anomalous lipid accumulation in the liver is a highly relevant factor contributing to liver diseases. However, the development of the reliable medications and their pharmacological mechanisms remain insufficient. Herein, a polyguanide nanoinhibitors (PGNI) depot is constructed by copolymerizing biguanide derivatives in different proportions onto prepolymers. The nanoinhibitors for their ability to ameliorate lipid accumulation in vitro and in vivo is screened, and subsequently demonstrated that covalently polymeric guanidine chains exhibit superior efficacy in ameliorating hepatic lipid accumulation via heterogeneous mechanisms compared to small‐molecule guanidine. It is found that PGNIs stabilize guanidine metabolism in the liver, preferably for biosafety. More importantly, PGNI is ingested and localized in hepatocyte lysosomes and is locked to interact with vesicular adenosine triphosphatase (V‐ATPase) on lysosomes, leading to the inhibition of V‐ATPase and lysosomal acidification, thereby activating the AMPK pathway, reducing fatty acid synthesis, and enhancing lipolysis and fatty acid oxidation. These results imply that polymer‐formed nanoparticles can serve as targeted inhibitors, offering a novel approach for therapeutic applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chongqing Medical University, College of Pharmacy, Chongqing Key Laboratory for Pharmaceutical Metabolism Research, Chongqing Pharmacodynamic Evaluation Engineering Technology Research Center, Chongqing, 400016, P. R. C…
- Centre for Lipid Research & Chongqing Key Laboratory of Metabolism on Lipid and Glucose, Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of…
ORCID-Profile: Yaxi Chen
Förderung
- National Natural Science Foundation of China
- National Key R&D Program of China
- Natural Science Foundation of Chongqing,
- The Science and Technology Research Program of Chongqing Municipal Education Commission
- Technological Innovation and Application Development Program of Chongqing
- Kuanren Talents Program of the second affiliated hospital of Chongqing Medical University
- Joint Project of Pinnacle Disciplinary Group, the Second Affiliated Hospital of Chongqing Medical
- Outstanding Graduate Student Cultivation Program of Chongqing Medical University
Zitieren
APA
Zhao, Y., Hu, K., Wang, F., Zhao, L., Su, Y., Chen, J., Zou, G., Yang, L., Wei, L., Deng, M., He, Y., Wang, P., Ruan, X. Z., Chen, Y., & Yu, C. (2025). Guanidine‐Derived Polymeric Nanoinhibitors Target the Lysosomal V‐ATPase and Activate AMPK Pathway to Ameliorate Liver Lipid Accumulation. Advanced Science. https://doi.org/10.1002/advs.202408906
Vancouver
Zhao Y, Hu K, Wang F, Zhao L, Su Y, Chen J, et al. Guanidine‐Derived Polymeric Nanoinhibitors Target the Lysosomal V‐ATPase and Activate AMPK Pathway to Ameliorate Liver Lipid Accumulation. Advanced Science. 2025. doi:10.1002/advs.202408906
BibTeX
@article{Zhao2025,
author = {Zhao, Yunfei and Hu, Ke and Wang, Fangliang and Zhao, Lulu and Su, Yu and Chen, Jun and Zou, Gang and Yang, Liming and Wei, Li and Deng, Mengjiao and He, Yunyu and Wang, Ping and Ruan, Xiong Z and Chen, Yaxi and Yu, Chao},
title = {Guanidine‐Derived Polymeric Nanoinhibitors Target the Lysosomal V‐ATPase and Activate AMPK Pathway to Ameliorate Liver Lipid Accumulation},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202408906}
}
EUVIMED